Bacterial Protein Toll-Like-Receptor Agonists: A Novel Perspective on Vaccine Adjuvants

by Sudeep Kumar, Raju Sunagar, Edmund Gosselin
Published 2019-05-01

Preclinical Efficacy of a Trivalent Human FcγRI-Targeted Adjuvant-Free Subunit Mucosal Vaccine against Pulmonary Pneumococcal Infection

by Sudeep Kumar, Raju Sunagar, Edmund J. Gosselin
Published 2020-04-01

Differential In Vitro Cultivation of Francisella tularensis Influences Live Vaccine Protective Efficacy by Altering the Immune Response

by Raju Sunagar, Sudeep Kumar, Sarah J. Rosa, Karsten R. O. Hazlett, Edmund J. Gosselin
Published 2018-07-01

Evaluation of an outbred mouse model for Francisella tularensis vaccine development and testing.

by Raju Sunagar, Sudeep Kumar, Prachi Namjoshi, Sarah J Rosa, Karsten R O Hazlett, Edmund J Gosselin
Published 2018-01-01

Downmodulation of Vaccine-Induced Immunity and Protection against the Intracellular Bacterium Francisella tularensis by the Inhibitory Receptor FcγRIIB

by Brian J. Franz, Ying Li, Constantine Bitsaktsis, Bibiana V. Iglesias, Giang Pham, Raju Sunagar, Sudeep Kumar, Edmund J. Gosselin
Published 2015-01-01

Preclinical testing of a vaccine candidate against tularemia.

by Ragavan Varadharajan Suresh, Zhuo Ma, Raju Sunagar, Vivek Bhatty, Sukalyani Banik, Sally V Catlett, Edmund J Gosselin, Meenakshi Malik, Chandra Shekhar Bakshi
Published 2015-01-01

Differential Growth of Francisella tularensis, Which Alters Expression of Virulence Factors, Dominant Antigens, and Surface-Carbohydrate Synthases, Governs the Apparent Virulence o...

by Kristen M. Holland, Sarah J. Rosa, Kolbrun Kristjansdottir, Donald Wolfgeher, Brian J. Franz, Tiffany M. Zarrella, Sudeep Kumar, Raju Sunagar, Anju Singh, Chandra S. Bakshi, Prachi Namjoshi, Eileen M. Barry, Timothy J. Sellati, Stephen J. Kron, Edmund J. Gosselin, Douglas S. Reed, Karsten R. O. Hazlett
Published 2017-06-01